Serum response factor mediates nociceptor inflammatory pain plasticity.

Area of Science:

• Neuroscience
• Molecular Biology
• Pain Research

Background:

• Chronic pain mechanisms involve altered gene expression in nociceptive neurons.
• Metabotropic glutamate receptor 5 (mGluR5) activation may influence A-Kinase Anchoring Protein 150 (AKAP150) in pain pathways.

Purpose of the Study:

• To investigate transcriptional changes in AKAP150 expression following prolonged mGluR5 agonist exposure.
• To identify the specific transcriptional elements, particularly Serum Response Factor (SRF), involved in AKAP150 regulation.

Main Methods:

• Primary cultures of rat dorsal root ganglia (DRG) were used to assess AKAP150 expression after mGluR5 agonist treatment.
• Serum response factor (SRF) was downregulated using siRNA in vitro and intrathecal oligonucleotides in vivo.
• Mechanical hypersensitivity and hyperalgesic priming were evaluated in vivo.

Main Results:

• SRF and AKAP150 were found to be coexpressed in TRPV1-positive DRG neurons.
• mGluR5 activation led to increased SRF-dependent transcription and AKAP150 expression, modulated by protein kinase C and SRF levels.
• In vivo knockdown of SRF attenuated mechanical hyperalgesic priming.

Conclusions:

• SRF-mediated transcription is crucial for the upregulation of AKAP150 and the development of hyperalgesic priming.
• SRF and AKAP150 signaling pathways are implicated in the transition from acute to chronic pain states.